Pay in 4 interest-free payments of $6.16 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Maybe you have more energy to work out
KoayYCChenYCWaliJALuk AWS LiMDomaHet al
Without analytical testing, you have no way to know
Epidemiologic studies have consistently shown a mortality advantage among patients with hematocrits in the 30% to 36% range, and the NKF-DOQI Work Group on Anemia Management recommended a target hematocrit of 33% to 36% based on the expert panels' detailed literature review
US$ 22.52
US$ 21.90
US$ 21.32
